Citation Impact
Citing Papers
Crippling life support for SARS-CoV-2 and other viruses through synthetic lethality
2020 StandoutNobel
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Origin of Antibiotics and Antibiotic Resistance, and Their Impacts on Drug Development: A Narrative Review
2023 Standout
HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B
2015
Stem Cell–Derived Culture Models of Hepatitis E Virus Infection
2018 StandoutNobel
Stem cell-derived hepatocytes: A novel model for hepatitis E virus replication
2015
The oncogenic role of hepatitis delta virus in hepatocellular carcinoma
2019
Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies
2018 StandoutNobel
Pan-Genotype Hepatitis E Virus Replication in Stem Cell–Derived Hepatocellular Systems
2017 StandoutNobel
Bile acid–microbiota crosstalk in gastrointestinal inflammation and carcinogenesis
2017 Standout
Multistate and functional protein design using RoseTTAFold sequence space diffusion
2024 StandoutNobel
De Novo Macrocyclic Peptide Inhibitors of Hepatitis B Virus Cellular Entry
2018
First-in-human application of the novel hepatitis B and hepatitis D virus entry inhibitor myrcludex B
2016
Insights From Antiviral Therapy Into Immune Responses to Hepatitis B and C Virus Infection
2018
A robust cell culture system supporting the complete life cycle of hepatitis B virus
2017 StandoutNobel
The role of liposomes in clinical nanomedicine development. What now? Now what?
2019 Standout
Burden of liver diseases in the world
2018 Standout
New antiviral targets for innovative treatment concepts for hepatitis B virus and hepatitis delta virus
2016
Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects
2020 Standout
Sex-dependent effects on gut microbiota regulate hepatic carcinogenic outcomes
2017
Hepatocellular carcinoma
2021 Standout
Spinoculation Enhances HBV Infection in NTCP-Reconstituted Hepatocytes
2015
A central hydrophobic E1 region controls the pH range of hepatitis C virus membrane fusion and susceptibility to fusion inhibitors
2019 StandoutNobel
Prevalence and burden of hepatitis D virus infection in the global population: a systematic review and meta-analysis
2018
Molecular biology of hepatitis B virus infection
2015
Attacking hepatitis B virus cccDNA – The holy grail to hepatitis B cure
2016
Global burden of liver disease: 2023 update
2023 Standout
Natural history of chronic hepatitis B virus infection
2014
Hepatitis B virus infection
2018
Host-directed therapies for bacterial and viral infections
2017
An RNA-centric dissection of host complexes controlling flavivirus infection
2019 StandoutNobel
Long-term hepatitis B infection in a scalable hepatic co-culture system
2017
Adaptive immunity in HBV infection
2016
Targeting the Achilles heel of the hepatitis B virus: a review of current treatments against covalently closed circular DNA
2015 StandoutNobel
Taming a beast: lessons from the domestication of hepatitis C virus
2019 StandoutNobel
Effects of amino acid substitutions in hepatitis B virus surface protein on virion secretion, antigenicity, HBsAg and viral DNA
2016 StandoutNobel
Stem cell-derived polarized hepatocytes
2020 StandoutNobel
Chronic viral hepatitis and its association with liver cancer
2017
Efficient evolution of human antibodies from general protein language models
2023
Estimating the Global Prevalence, Disease Progression, and Clinical Outcome of Hepatitis Delta Virus Infection
2019
Hepatocellular Carcinoma
2019 Standout
Optimization-by-design of hepatotropic lipid nanoparticles targeting the sodium-taurocholate cotransporting polypeptide
2019
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
Sexually Transmitted Infections Treatment Guidelines, 2021
2021 Standout
Sexually Transmitted Diseases Treatment Guidelines, 2010
2011 Standout
Present and future therapies of hepatitis B: From discovery to cure
2015
Repurposing approved drugs on the pathway to novel therapies
2019
The Interferon-Inducible Protein Tetherin Inhibits Hepatitis B Virus Virion Secretion
2015
NTCP and Beyond: Opening the Door to Unveil Hepatitis B Virus Entry
2014
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
Viral persistence, liver disease, and host response in a hepatitis C–like virus rat model
2017 StandoutNobel
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
De Novo Carborane-Containing Macrocyclic Peptides Targeting Human Epidermal Growth Factor Receptor
2019 StandoutNobel
Scalable mRNA and siRNA Lipid Nanoparticle Production Using a Parallelized Microfluidic Device
2021 StandoutNobel
CRISPR-Cas Targeting of Host Genes as an Antiviral Strategy
2018
In vivo models of hepatitis B and C virus infection
2016
New Methods in Tissue Engineering: Improved Models for Viral Infection
2014 StandoutNobel
Works of Florian A. Lempp being referenced
a proof-of-concept Phase 2a clinical trial with Hbv/hdv entry inhibitor Myrcludex B : lb-20
2014
Inhibitors of Hepatitis B Virus Attachment and Entry
2014
Evidence that hepatitis B virus replication in mouse cells is limited by the lack of a host cell dependency factor
2015
Treatment of chronic hepatitis D with the entry inhibitor myrcludex B: First results of a phase Ib/IIa study
2016
Hepatitis B and D Viruses Exploit Sodium Taurocholate Co-transporting Polypeptide for Species-Specific Entry into Hepatocytes
2013
HBV Bypasses the Innate Immune Response and Does Not Protect HCV From Antiviral Activity of Interferon
2018
Hepatitis delta virus: insights into a peculiar pathogen and novel treatment options
2016
Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor
2013
Sodium taurocholate cotransporting polypeptide is the limiting host factor of hepatitis B virus infection in macaque and pig hepatocytes
2017
Impaired uptake of conjugated bile acids and hepatitis b virus pres1‐binding in na+‐taurocholate cotransporting polypeptide knockout mice
2015
Predicting the mutational drivers of future SARS-CoV-2 variants of concern
2022